Presentations

Dhumal G, DeLuca A, Chandanwale A, Kadam D, Joshi S, Kinikar A, Suryavanshi N, Mave V, Gupta A, Bollinger R. Impact of Fogarty HIV-TB Training Program on ‘Institutional Research Capacity Building’ at the Byramjee Jeejeebhoy Government Medical College (BJGMC), Pune, India. Session: Building...

Gestational Diabetes Suppresses the Inflammatory Response to M. tuberculosis in Pregnant Women in Pune, India. Session: Clinical Investigation for TB and Diabetes

Post Date:

2018-10-27

Mathad J, Alexander M, Bhosale R, Shere D, Kulkarni V, Kumar P, Babu S, Gupta A for the PRACHITi Study team. Gestational Diabetes Suppresses the Inflammatory Response to M. tuberculosis in Pregnant Women in Pune, India. Session: Clinical Investigation for TB and Diabetes. 49th Annual Union World...

TB Stigma and Its Impact on Enrolling Household Contacts in Clinical Trials and Cohort Studies: An Indian Perspective

Post Date:

2018-10-27

Suryavanshi N. TB Stigma and Its Impact on Enrolling Household Contacts in Clinical Trials and Cohort Studies: An Indian Perspective. Symposium: Tuberculosis Contact Investigation in High Tuberculosis Burden Settings. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands...

Managing Tuberculosis in Pregnancy. Meet the Expert Session

Post Date:

2018-10-26

Gupta A. Managing Tuberculosis in Pregnancy. Meet the Expert Session. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands. October 24-27, 2018.

Factors Associated with Loss to Follow-up and Mortality in Public Sector MDR TB Treatment in Western Maharashtra, India from 2015-2016

Post Date:

2018-10-26

Murrill M, More SW, Kamble S, Kulkarni V, Dowdy D, Gupta A. Factors Associated with Loss to Follow-up and Mortality in Public Sector MDR TB Treatment in Western Maharashtra, India from 2015-2016. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands. October 24,-27, 2018.

The TEKO trial: implementation of the QuantiFERON®-TB Gold In-Tube test at CD4 blood draw for diagnosing latent tuberculosis among newly diagnosed HIV-infected adults in South Africa

Post Date:

2018-10-26

Golub J, Lebina L, Chon S, Cohn S, Jack T, Masonoke K, Variava E, Martinson N, TEKO team. The TEKO trial: implementation of the QuantiFERON®-TB Gold In-Tube test at CD4 blood draw for diagnosing latent tuberculosis among newly diagnosed HIV-infected adults in South Africa. 49th Annual Union World...

Utility of QGIT as an Adjunct to TST for Screening of Latent Tuberculosis Infection among Indian Healthcare Workers

Post Date:

2018-10-26

Girish S, Kinikar A, Pardeshi G, Shelke S, Basavaraj A, Chandanwale A, Gupte N, Bollinger R. Utility of QGIT as an Adjunct to TST for Screening of Latent Tuberculosis Infection among Indian Healthcare Workers. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands. October 24...

Mortality Risk Doubled in Tuberculosis Patients with Diabetes Not Receiving Metformin

Post Date:

2018-10-26

Mave V, Gupte N, Gaikwad S, Barthwal M, Chon S, Gupte A, Gupta A, Golub J. Mortality Risk Doubled in Tuberculosis Patients with Diabetes Not Receiving Metformin. Presented at 49th Union World Conference on Lung Health. The Hague, The Netherlands. October 24-27, 2018.

Addressing policy needs for controlling TB and multidrug-resistant TB (MDR-TB): a biosocial inquiry among patients in Pune city in Western Maharashtra, India

Post Date:

2018-10-26

Atre S. Addressing policy needs for controlling TB and multidrug-resistant TB (MDR-TB): a biosocial inquiry among patients in Pune city in Western Maharashtra, India. Presented at 49th Union World Conference on Lung Health. The Hague, The Netherlands. October 24-27, 2018.

What Is the Right Dose of Pyrazinamide?

Post Date:

2018-10-25

Dooley K. What Is the Right Dose of Pyrazinamide? Symposium: Optimisation of Standard Drugs in the Treatment of Tuberculosis, Finally?

BRIEF TB Treatment of Latent TB Infection With One Month of Isoniazid & Rifapentine in HIV-Infected People: Interaction of Treatment & CD4 Count

Post Date:

2018-10-25

Swindells S, Ramchandami R, Gupta A, Sanchez J, Juste MAJ, Mwelase N, Chaisson R, BRIEF TB Study Team. BRIEF TB Treatment of Latent TB Infection With One Month of Isoniazid & Rifapentine in HIV-Infected People: Interaction of Treatment & CD4 Count. Session: TB Infection: From Latent to...

Impact of Maternal Isoniazid Preventive Therapy (IPT) Timing on Acquisition of Infant TB Infection (TBI) in the IMPAACT P1078/TB APPRISE Trial

Post Date:

2018-10-25

Gupta A , Aaron L, Montepiedra G, Theron G, Chipato T, Onyango-Makumbi C, Stranix-Chibanda L, Weinberg A, for the IMPAACT P1078/TB APPRISE Study Team. Impact of Maternal Isoniazid Preventive Therapy (IPT) Timing on Acquisition of Infant TB Infection (TBI) in the IMPAACT P1078/TB APPRISE Trial. 49th...

Preventive Therapy for PLWH - 3HP. MTE HIV Meet the Expert Session

Post Date:

2018-10-25

Dooley K. Preventive Therapy for PLWH - 3HP. MTE HIV Meet the Expert Session. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands. October 24-27, 2018.

Alcohol Use Disorder, Drinking Patterns, and Tuberculosis Treatment Failure in Indian Patients

Post Date:

2018-10-25

DeLuca A, Thomas B, Suryavanshi N , Jain D, Paradkar M, Gupte A, Chandrasekaran P, Gupta A for the CTRIUMPH RePORT India Study Team. Alcohol Use Disorder, Drinking Patterns, and Tuberculosis Treatment Failure in Indian Patients. 49th Annual Union World Conference on Lung Health. The Hague, The...

Interleukin-6, Interleukin-13 and Interferon-γ as Potential Biomarkers for Treatment Failure in Pulmonary Tuberculosis

Post Date:

2018-10-25

Countries:

Gupte A, Kumar P, Kulkarni V, Bharadwaj R, Andrade B, Mave V, Chandrasekaran P, Gupta A. Interleukin-6, Interleukin-13 and Interferon-γ as Potential Biomarkers for Treatment Failure in Pulmonary Tuberculosis. 49th Annual Union World Conference on Lung Health. The Hague, The Netherlands. October 24-...

Challenges in TB Diagnosis in Pregnant Women in India: Findings from a Cohort Study in Pune, India

Post Date:

2018-10-25

Alexander M, Bhosale R, Gupte N, Deshpande P, Kulkarni V, Chandanwale A, Gupta A, Mathad J. Challenges in TB Diagnosis in Pregnant Women in India: Findings from a Cohort Study in Pune, India. Session: LTBI Screening: Challenges and Opportunities. 49th Annual Union World Conference on Lung Health...

Sub-therapeutic Rifampicin Concentration is Associated with Unfavourable Treatment Outcomes in Pulmonary Tuberculosis Patients on Thrice Weekly Regimens in India

Post Date:

2018-10-25

Ramachandran G, Chandrasekaran P, Kumar AKH, Kannan T, Gomathi NS, Gaikwad S, Gupta A, Mave V, for C-TRIUMPh team. Sub-therapeutic Rifampicin Concentration is Associated with Unfavourable Treatment Outcomes in Pulmonary Tuberculosis Patients on Thrice Weekly Regimens in India. Session: Clinical...

Host Inflammation Markers IFN- γ, IL-6 and IL-15 Strongly Associated with Risk of Incident TB in Advanced HI

Post Date:

2018-10-25

Manabe YC, Gupte N, Leong S, Kintali M, Bisson G, Hosseinipour M, Salgame P, Gupta A for the ACTG 5274 REMEMBER and NWCS 408 Study Team. Host Inflammation Markers IFN- γ, IL-6 and IL-15 Strongly Associated with Risk of Incident TB in Advanced HI. Session: Diagnosis, Screening, Prediction of Disease...

Time to culture conversion, identifying independent modifiable risk factors in Indian patients

Post Date:

2018-10-25

Gupte N, Gupte A, Sivaramakrishnan GN, Pradhan N, Shivakumar SVBY, Gupta A, Mave V, Chandrasekaran P for the CTRIUMPh RePORT India team. Time to culture conversion, identifying independent modifiable risk factors in Indian patients. Presented at 49th Union World Conference on Lung Health. The Hague...

BWI CTU: Baltimore-Washington-India Clinical Trials Unit

Post Date:

2007-02-02

Countries:

Clinical Sites:

Comprising clinical trial sites at Johns Hopkins Medicine in Baltimore, Whitman Walker Health in Washington, DC, and the BJGMC-CCGHE collaboration in Pune, India, the Baltimore-Washington-India Clinical Trials Unit (BWI-CTU) is one of only 25 international HIV/TB clinical trial sites funded by the...

BJGMC-JHU Fogarty HIV-TB Training Program

Post Date:

2007-01-01

Countries:

Clinical Sites:

Funded by the Fogarty International Center at the National Institutes of Health, the JHU Fogarty program has nearly 20 years of success with providing training, professional development, and mentorship to clinicians and scientists in low and middle income countries. CCGHE's latest efforts in this...

Impact of Malnutrition on HIV Treatment Failure in Resource-limited Settings

Post Date:

2010-01-01

Countries:

Clinical Sites:

Highly active antiretroviral therapy (HAART) has reduced morbidity and mortality among HIV-infected persons worldwide. However, early treatment failure (i.e. WHO stage 3 or 4 illnesses or death during the first 24 months of HAART) is more than 3-fold higher in resource limited settings (RLS) than...

RePORT: C-TRIUMPH: Cohort for Tuberculosis Research by the Indo-US Medical Partnership

Post Date:

2013-09-28

Countries:

Clinical Sites:

NIRT

Collaboratively funded by the US NIH, India’s Department of Biotechnology [DBT], and Indian Council of Medical Research, the Cohort for TB Research by the Indo-US Medical Partnership (C-TRIUMPH) is an Indo-US research consortium that is part of RePORT India, a countrywide consortium for TB research...

C-TRIUMPH Pilot Study: Burden and Risk Factors for Drug-resistant Tuberculosis in Pune, India

Post Date:

2012-05-29

Countries:

Clinical Sites:

This pilot study ended in April 2015. Drug resistant TB (MDR-TB and XDR-TB) is increasing worldwide. Although 20% of all global TB cases occur in India, current estimates of the burden of MDR-TB in India are limited. A well-characterized TB clinical cohort, household cohort and control cohort would...

Diagnosis of Active Tuberculosis in HIV-infected and Uninfected Young Children in India

Post Date:

2012-07-24

Countries:

Clinical Sites:

Tuberculosis (TB) is the most common cause of morbidity/mortality in HIV-infected individuals in India. India has the world's highest burden of HIV and TB, and since children acquire HIV/TB from their caregivers, active TB is highly prevalent (14-67.5%) among HIV-infected young children in India...

Hair Concentrations of Anti-tuberculosis Drugs Among HIV-infected and Uninfected Children in India

Post Date:

2013-05-07

Countries:

Clinical Sites:

NIRT

In the developing world, tuberculosis (TB) is a major cause of mortality among HIV-infected children, a population where measuring treatment adherence and drug levels is difficult. We propose an innovative therapeutic drug monitoring (TDM) tool that measures drug concentration in hair samples to...

A Prospective Study Evaluating the Role of Cryptococcal Antigen Screening among HIV-infected Adults with Low CD4 Counts

Post Date:

2011-01-01

Countries:

Clinical Sites:

This prospective observational study aimed to evaluate the burden of cryptococcal disease among approximately 200 HIV-infected adults with low CD4 cell counts in Pune, India to determine whether a Cryptococcal screening strategy should be the standard of care among patients with advanced HIV...

Mother-to-Child Transmission (MTCT) of HIV: India SWEN Study

Post Date:

2002-06-07

Countries:

Clinical Sites:

This study was officially terminated August 2018. Primary and secondary analyses of the India SWEN study, an NIH-funded phase III randomized controlled trial of an extended nevirapine prophylaxis regimen among 783 HIV-infected pregnant women and their breastfed infants in Pune, India.

RePORT: C-TRIUMPH: Substudy on Assessing the Association of Indoor Air Pollution with Tuberculosis in Adult Women and Children under 5 Years of Age

Post Date:

2013-09-15

Countries:

Addressing social and environmental risk factors contributing to TB disease is becoming increasingly important for national TB programs. We are leveraging the pediatric participants in 1,100 homes participating in the C-TRIUMPH study, enhancing data collection regarding household and individual...

Diagnosis of Tuberculosis Infection and Th1 Immune Response in Pregnant Women in India

Post Date:

2014-09-01

Countries:

Clinical Sites:

NIRT

This study was terminated April 16, 2018. Tuberculosis (TB) disease is a major cause of mortality among Indian women of reproductive age; approximately 20-50% of women in India are latently infected with Mycobacterium tuberculosis (MTB). Due to immune changes of pregnancy, women are particularly at...

Tuberculosis Noon Conference

Post Date:

2013-10-24

Countries:

Clinical Sites:

This effort ended in 2015. As part of the BJGMC-Johns Hopkins India Fogarty Training Program, from 2013-2015 CCGHE hosted the live Tuberculosis Noon Conference webcast. Led by Drs. Maunank Shah, Jonathan Golub, and Richard Chaisson, these webcast meetings brought together Johns Hopkins TB...

TB Case Conference

Post Date:

2013-02-25

Countries:

CCGHE broadcasts live TB Case Conferences and provides a global audience with open access to all live and archived webcasts via the CCGHE website. Hosted by Dr. Maunank Shah (Johns Hopkins), this case-based conference serves as a forum where clinicians caring for individuals with active TB can...

ONCOGRID: An mHealth Approach to Prevention and Early Diagnosis of Oral Cancer in Rural South India

Post Date:

2012-11-01

Countries:

Democratic Republic of Congo

This study ended February 7, 2017. The Indian sub-continent is burdened with 80% of the world’s patients with oral cancer, and delay in oral cancer diagnosis is one of the major problems that leads to poor treatment outcomes (V. Shanta, R. Swaminathan, R. Rama. Cancer Control 2013). Current...

Johns Hopkins Infectious Diseases (ID) Grand Rounds

Countries:

CCGHE broadcasts monthly Johns Hopkins (JH) Infectious Diseases (ID) Grand Rounds to centers in the Democratic Republic of Congo as an initial inroad to improve clinical education. ID Grand Rounds is an educational conference where JH faculty and trainees discuss clinical cases from the JH Hospital...

EXposure Assessment in Current Time (EXACT) study

Post Date:

2008-11-01

Countries:

Injection drug users (IDUs) are a marginalized population with substantial disparities in healthcare outcomes, especially among the HIV-infected IDU population. The EXACT study, which ended in 2013, was designed to optimize time to antiretroviral treatment (ART) initiation and retention-in-care...

Technology-enhanced Peer Navigation to Improve Injection Drug User (IDU) Engagement in HIV Care

Post Date:

2000-01-01

Countries:

This study is evaluating an mHealth-enhanced peer navigation intervention for improving retention-in-care and adherence to antiretroviral therapy (ART) for out-of-care, HIV-infected injection drug users (IDUs). The CCGHE-developed emocha® is assisting peer navigators (former IDUs successfully...

DOmestic Violence Enhanced Home Visitation and Smart Phones (DOVE)

Post Date:

2012-01-01

Countries: